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Abstract
Background
Maternally-derived duplications of the 15q11-q13 region are the most frequently reported chromosomal aberrations in autism
spectrum disorders (ASD). Prader-Willi and Angelman syndromes, caused by 15q11-q13 deletions or abnormal methylation of
imprinted genes, are also associated with ASD. However, the prevalence of these disorders in ASD is unknown. The aim of this study
was to assess the frequency of 15q11-q13 rearrangements in a large sample of patients ascertained for ASD.
Methods
A total of 522 patients belonging to 430 families were screened for deletions, duplications and methylation abnormalities involving
15q11-q13 using multiplex ligation-dependent probe amplification (MLPA).
Results
We identified four patients with 15q11-q13 abnormalities: a supernumerary chromosome 15, a paternal interstitial duplication, and
two subjects with Angelman syndrome, one with a maternal deletion and the other with a paternal uniparental disomy.
Conclusions
Our results show that abnormalities of the 15q11-q13 region are a significant cause of ASD, accounting for approximately 1  of%
cases. Maternal interstitial 15q11-q13 duplications, previously reported to be present in 1  of patients with ASD, were not detected in%
our sample. Although paternal duplications of chromosome 15 remain phenotypically silent in the majority of patients, they can give
rise to developmental delay and ASD in some subjects, suggesting that paternally-expressed genes in this region can contribute to
ASD, albeit with reduced penetrance compared to maternal duplications. These findings indicate that patients with ASD should be
routinely screened for 15q genomic imbalances and methylation abnormalities and that MLPA is a reliable, rapid and cost-effective
method to perform this screening.
MESH Keywords Adolescent ; Adult ; Angelman Syndrome/ genetics ; Autistic Disorder/ genetics ; Child ; Child, Preschool ; Chromosome Aberrations ; Chromosomes,
Human, Pair 15, genetics ; DNA Methylation/ genetics ; Female ; Gene Deletion ; Gene Dosage ; Humans ; Male ; Microsatellite Repeats/ genetics ; Prader-Willi Syndrome/
genetics ; Uniparental Disomy
Author Keywords autism ; chromosome 15 ; deletion ; duplication ; Angelman syndrome ; MLPA
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Introduction
Autism is a neurodevelopmental disorder characterized by impaired social interaction and communication, and a restricted range of
interests and activities, with onset during the first three years of life. Autism spectrum disorders (ASDs), which include autism, pervasive
developmental disorder not otherwise specified (PDD-NOS) and Asperger syndrome, have a typical male preponderance and their
estimated prevalence is 6/1000 ( ). ASDs are etiologically heterogeneous, with an underlying genetic disorder identified in 10 25  of1 %– %
cases. Monogenic disorders such as fragile X syndrome, tuberous sclerosis, and Rett syndrome are found in a small percentage of patients;
in addition, rare mutations in other genes (e.g., ) have been reported in a small number ofNLGN3, NLGN4X, PTEN, SHANK3 
individuals ( ). Cytogenetically visible chromosomal aberrations are identified in 3 6  of affected individuals ( , ), while recent2 %– % 3 4 
higher-resolution whole-genome analyses using array-based technologies have revealed genomic imbalances in at least 10  of cases (% 5 –7 
).
Duplications of the 15q11-q13 region are the most frequently reported chromosomal aberration in individuals with ASDs ( ). This8 
region includes the Prader-Willi syndrome/Angelman syndrome (PWS/AS) critical region, which is subject to genomic imprinting. Most
duplications of this interval are caused by supernumerary chromosomes formed by the inverted duplication of proximal 15q, known as
isodicentric chromosome 15 idic( )  ( ). Interstitial duplications of this region are less frequent ( ), but many cases have been[ 15 ] 9 –13 14 
reported in association with autism ( , , ). The majority of cases are associated with maternally-derived duplications, whereas10 13 15 –17 
paternal inheritance usually leads to normal phenotypes ( , , , ).10 15 16 18 
Deletions or methylation abnormalities of chromosome 15 result in either Prader-Willi syndrome or Angelman syndrome, depending
on whether they arise on the paternal or maternal chromosome. Both syndromes have been described in patients with ASD or autistic
behavior, and recent studies estimate that over half of the patients with Angelman syndrome have ASD ( ).19 –21 
The genomic instability of proximal chromosome 15 is mediated by low-copy repeats, resulting in five recurrent breakpoints (BP)
involved in deletions, duplications and idic( ) ( ). The deletions involve either the proximal BP1 or BP2 and share the same distal15 22 
breakpoint (BP3), whereas the duplications can extend more distally to BP4 or BP5 ( ). The critical region involved in PWS/AS andFig. 1 
the 15q11-q13 duplication syndrome lies between BP2 and BP3. Nonallelic homologous recombination between flanking low-copy repeats
is also involved in other microdeletion/microduplication syndromes associated with mental retardation and ASDs, including 17p11.2,
22q11.2 and 7q11.23 ( ).23 
Although the frequency of 15q11-q13 duplications in autism is widely assumed to be 1 3 , this estimate is based on two small%– %
series of patients. In a study of 140 subjects with autism, two were found with a maternal interstitial duplication of 15q11-q13 ( ).24 
Schroer studied 100 patients with autism and identified two idic( ), one maternally-derived interstitial duplication and one maternalet al. 15 
deletion ( ). The small numbers of patients studied makes it difficult to draw conclusions on the real contribution of such duplications to10 
ASD. The prevalence of proximal 15q deletions in ASDs is also unknown. Recent genome-wide studies of copy number variants in large
ASD samples included an unknown proportion of patients who had been previously screened for chromosomal abnormalities and
15q11-q13 rearrangements (and excluded if positive), thus precluding the estimation of prevalence ( , ).5 6 
The aim of this study was to assess the frequency of 15q11-q13 abnormalities in 522 individuals with ASDs. We screened the
PWS/AS region for gene dosage alterations using multiplex ligation-dependent probe amplification (MLPA) and quantitative
microsatellite analysis. In addition, we searched for methylation abnormalities of chromosome 15, including uniparental disomies and
imprinting center defects, using methylation-sensitive MLPA ( ). Epigenetic defects have long been suspected in autism ( , ), but25 26 27 
no systematic screening of methylation abnormalities of chromosome 15 had been performed.
Methods and Materials
Patients
A total of 522 patients with ASD belonging to 430 families were studied. Subjects were recruited by the Paris Autism Research
International Sibpair (PARIS) study at specialized clinical centers in Europe and the United States. The patients included 393 males and
129 females (ratio 3:1), with a mean age at the last evaluation of 11 7.5 years (range 2.5 43); 187 belonged to 95 multiplex families (with± –
two or more affected siblings) and 335 were sporadic cases. All patients were evaluated by psychiatrists or child neurologists and
diagnosed based on clinical evaluation and DSM-IV criteria. Patients were assessed with the Autism Diagnostic Interview-Revised
(ADI-R) ( ) and the Asperger Syndrome Diagnostic Interview ( ). Four-hundred seventy-two individuals met criteria for autism, 2628 29 
for Asperger syndrome and 24 for PDD-NOS. Three-hundred fifty-six patients (68 ) had mental retardation, 261 (50 ) had very limited% %
or no language, and 66 (13 ) had a history of epilepsy. Most patients were Caucasian (89 ). Laboratory tests included karyotype, fragile% %
X and metabolic screening; brain imaging and EEG were performed when possible. Patients with known genetic disorders were excluded.
Chromosome analysis identified one female harboring a supernumerary isodicentric derivative chromosome 15; we report here the
cytogenetic, molecular and phenotypic characterization of this patient. No other patients had been excluded from the sample prior to this
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study because of cytogenetic abnormalities of chromosome 15q11-q13. The study was approved by the research ethics boards of the
collaborating institutions. Informed consent was obtained from all families participating in the study.
Multiplex ligation-dependent probe amplification (MLPA)
Patients were screened for rearrangements involving the 15q11-q13 region using the ME028 PWS/AS and/or the P064 MR1 MLPA
kits (n 351 and 522, respectively) (MRC-Holland). The ME028 kit contains 25 probes specific for sequences in or near the PWS/AS=
critical region, as well as 5 probes to assess methylation status ( ). The P064 kit contains 5 probes in the PWS/AS region (one probe in 25 
and and two in MLPA data were analyzed using GeneMarker 1.70 software (SoftGenetics). AfterMKRN3, NDN, GABRB3, UBE3A). 
population normalization, the peak height from each sample was compared to a synthetic control, which represents the median of all
normal samples in each experiment. Peak heights below 0.75 were considered as deletions and values above 1.3 as duplications. Cases
with apparent deletions or duplications were confirmed with quantitative PCR (qPCR) and fluorescent in situ hybridization (FISH).
Apparent deletions of a single probe were sequenced to rule out single-base changes within the probe-binding region. For further details
see Supplement 1.
Quantitative microsatellite analysis
Five microsatellite markers in the 15q11-q13 region (D15S11, D15S817, D15S1513, D15S1019 and D15S815) were used to assess
DNA copy number and follow the transmission of the alleles ( ). PCR conditions (in particular the number of PCR cycles) were setFig. 1 
up so as to perform allele dosage. PCR products were quantified on an ABI3730 sequencer (Applied Biosystems).
Results
Five quantitative assays using microsatellites were used to screen the 15q11-q13 region in 217 patients. However, analysis of the
markers D15S11 and D15S817 revealed three alleles in 10  of patients, a proportion comparable to that in a control population, indicating%
that this region is duplicated in healthy individuals. We therefore decided to screen all patients using MLPA.
Overall, we identified four patients with 15q11-q13 abnormalities considered to be pathogenic: an idic( ), an interstitial duplication,15 
a deletion and an uniparental disomy. Their clinical features are summarized in and are described in more detail in Supplement 1.Table 1 
Supernumerary isodicentric chromosome 15
Patient 1 had an idic( ) revealed by the karyotype and confirmed by FISH, described as 47,XX, mar.ish der( )(D15Z1 , SNRPN15 + 15 ++
, UBE3A ) ( ). Microsatellite analysis of the patient and her parents showed that she had a copy number gain of++ ++ Fig. 2A de novo 
D15S11, D15S817 and D15S815 ( ). Methylation-sensitive MLPA revealed that the idic( ) was maternally-derived, as indicatedFig. 2B 15 
by the increased dosage of the methylated probes in and ( ). MLPA confirmed that the idic( ) involved all the probesSNRPN NDN Fig. 3 15 
in the 15q11-q13 region (between BP1 and BP3) but did not affect two genes located distally, at 15q26, and ( ).BLM IGF1R Fig. 2C 
Further analysis of the 15q11-q13 interval with 15 microsatellites showed six triallelic markers, with one allele of paternal origin and two
of maternal origin ( ). One informative microsatellite between BP4 and BP5, D15S1031, had a single maternal allele, suggestingFig. 2D 
the breakpoint lies proximal to this marker ( ). Detailed investigation of the distal breakpoint with qPCR showed increased dosageFig. 2D 
of and located between BP4 and BP5, but two distal genes in the same interval, and MTMR10, TRPM1 KLF13, OTUD7A CHRNA7, 
showed a normal copy number ( ). These findings suggest that the distal breakpoint of the idic( ) lies between BP4 and BP5, inFig. 2E 15 
agreement with the microsatellite results. The probeb showed an increase in dosage to the hexasomy range, suggesting a complexKLF13 
rearrangement at the site of the breakpoint. We could not differentiate between one or two breakpoints, because of the inability to estimate
the precise copy number of individual probes on the basis of qPCR ( ).Fig. 2E 
Interstitial 15q11-q13 duplication
Patient 2 had three alleles for both D15S11 and D15S817. He was homozygous for D15S1513 and D15S1019, which were therefore
uninformative, and heterozygous without imbalance for D15S815, located between BP3 and BP4 (not shown). MLPA confirmed the
presence of a ~4.6 Mb duplication between BP2 and BP3, corresponding to the critical region deleted in PWS/AS ( ).Fig. 4 
Methylation-sensitive MLPA showed normal dosage of the methylated maternal probes in and indicating that theSNRPN NDN, 
duplication was paternally derived ( ). MLPA of the parents showed that the duplication was inherited from the unaffected father (Fig. 3 
). Methylation analysis of the father showed a paternal origin of the duplication (not shown), but no DNA was available from theFig. 4 
grandfather to determine if the duplication was inherited or had arisen FISH using the UBE3A probe confirmed the presence ofde novo. 
an increased signal in Patient 2 (not shown).
Angelman syndrome: deletion and uniparental disomy
Patients 3 and 4 had only one allele for three markers located in the PWS/AS region (D15S11, D15S817 and D15S1513), suggesting
that they could be either homozygous or deleted in this region ( ). Examination of the parents  haplotypes showed that both patientsFig. 5A ’
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had only one allele from the father and none from the mother ( ). MLPA confirmed that Patient 3 had a maternal class I deletionFig. 5A 
extending ~5.6 Mb from BP1 to BP3 that arose ( , ). FISH with probe D15S10 confirmed the deletion (not shown). Inde novo Fig. 3 5C 
Patient 4, MLPA showed a normal copy number of the 15q11-q13 region ( ) but methylation-sensitive MLPA revealed a completeFig. 5C 
absence of maternal methylated DNA sequences, indicating a paternal uniparental disomy ( ). FISH showed normal hybridization ofFig. 3 
probes SNRPN and D15S10 (not shown), consistent with the diagnosis of uniparental disomy.
Abnormal copy number of the BP1-BP2 region
MLPA also detected three patients with a deletion (Patients 5, 6 and 7) and two with a duplication (Patients 8 and 9) of the BP1-BP2
interval, which spans 254 kb and encompasses four genes, and ( ). All the rearrangements wereTUBGCP5, CYFIP1, NIPA1, NIPA2 Fig. 1 
inherited from parents who were unaffected or had unrelated psychiatric disorders ( ).Table 1 
The cytoplasmic FMR1 interacting protein 1 (CYFIP1) interacts with FMRP, encoded by the fragile X mental retardation 1 (FMR1) 
gene. Since fragile X syndrome is often associated with autism, constitutes a candidate gene for autism. In order to test theCYFIP1 
possibility that point mutations in this gene, either inherited from the other parent or could lead to autism in association with thede novo, 
BP1-BP2 imbalance, we sequenced the whole coding region of in the five probands with abnormal dosage of this region. InCYFIP1 
Patients 5 and 8 we extended the search of point mutations to the coding regions of and as well as those NIPA1, NIPA2 TUBGCP5, of
and which encode proteins of the FMRP complex. No mutations were identified in any of the genes screened.FMR1, FXR1 FXR2, 
Other deletions or sequence variants considered non pathogenic
We identified one patient with a paternally-inherited deletion of exon 1 in one of the transcript variants of the gene. BecauseUBE3A 
the deleted exon is noncoding and is maternally expressed, this genomic imbalance is unlikely to have clinical consequences. InUBE3A 
another patient, MLPA showed an apparent deletion of one probe in the promoter/exon1 region, due to a maternally-inheritedSNRPN 
nucleotide change previously reported as a rare neutral variant (see Supplement 1 for further details on these two patients).
Methylation abnormalities
Aside from the uniparental disomy identified in Patient 4, no other methylation abnormalities were observed in 331 patients screened
with methylation-sensitive MLPA. In the remaining subjects, uniparental disomy was ruled out with microsatellite analysis.
Discussion
In this study, we found a pathogenic rearrangement of the 15q11-q13 region in 4 out of 430 families. Thus, proximal 15q
abnormalities, including deletions, supernumerary isodicentric chromosomes and interstitial duplications, are found in about 1  of patients%
with ASD, representing one of the most common genetic causes of ASD, together with fragile X syndrome.
Supernumerary chromosome 15 and ASD
Supernumerary marker chromosomes are a relatively common cytogenetic finding, with an estimated incidence of 0.8/1000 prenatal
diagnoses; those derived from chromosome 15 account for about half of all marker chromosomes ( ). The frequency is higher in children30 
with developmental delay, with 10 idic( ) identified in 2000 such cases in one study ( ). Idic( ) that do not include the PWS/AS15 11 15 
critical region have no clinical effect ( ), whereas those including the PWS/AS region lead to a neurobehavioral phenotype including31 
autism or autistic-like behavior, cognitive deficits, hypotonia, mild dysmorphic features, and seizures ( ). There have been numerous32 
reports of idic( ) associated with autism ( ). As in Patient 1, the vast majority of idic( ) that encompass the PWS/AS locus are15 9 –13 15 
maternally derived and arise ( ). Almost two-thirds extend beyond BP3 and the majority are asymmetrical, with two distinctde novo 33 
breakpoints, at BP4 and BP5 ( , ). Analysis of the number of copies across the 15q11-q13 region in Patient 1 with qPCR and14 33 
microsatellites predicted an atypical distal breakpoint between BP4 and BP5. A similar breakpoint was reported in a patient with an idic(15
), between D15S1013 andD S1031 ( ).! 33 
Although genotype/phenotype correlation studies show that the segmental tetrasomy of idic( ) is associated with a more severe15 
phenotype in terms of developmental outcome compared to interstitial triplications or duplications, indicating a dosage effect, no clear
correlation has been observed between gene dosage and autism phenotype ( ). Furthermore, no consistent relationship has been observed34 
between rearrangement size and clinical severity ( , ).11 34 
Interstitial duplications and ASD
At least 33 cases of interstitial duplications of the 15q11-q13 region have been reported in association with ASDs, according to the
Autism Chromosome Rearrangement Database ( ). Interstitial duplications of proximal 15q that do nothttp://projects.tcag.ca/autism/ 
include the PWS/AS critical region have no clinical effect, are usually familial and may be considered normal variants ( ). Patients with18 
interstitial duplications of the PWS/AS locus have an abnormal phenotype that includes developmental delay, particularly affecting speech
Biol Psychiatry . Author manuscript
Page /5 13
and language, varying degrees of mental retardation, autism or autistic features, motor coordination difficulties, and mild or no dysmorphic
features ( ). The phenotype is highly variable, even among members of the same family carrying identical rearrangements ( ) and can16 16 
in some cases manifest as developmental language disorder and dyspraxia, without autism ( ). The clinical findings in Patient 2 are35 
similar to those described in patients with maternal 15q11-q13 duplications, although he lacks the hypotonia, motor coordination problems
and joint laxity observed in other cases ( , ).16 17 
The frequency of 15q11-q13 interstitial duplications is estimated at 1:600 individuals referred with developmental delay ( ).36 
Although previous studies in small samples of patients had suggested a frequency of 1  for maternally-derived interstitial duplications in%
autism ( , ), we did not detect any such cases in our sample but found one patient harboring a paternal 15q11-q13 duplication. In10 24 
agreement with our findings, Bolton screened 181 patients with autism and found only one interstitial duplication of paternal origin (et al. 
). Similarly, Thomas studied 327 samples referred for a suspected ASD as well as 87 patients with confirmed autistic disorder and37 et al. 
found no 15q duplications ( ). More recently, a genome-wide microarray study of 427 subjects with ASD identified two36 
maternally-derived 15q11-q13 duplications ( ). Collectively, these results suggest that maternal interstitial duplications are less frequent7 
than previously assumed, with an estimated ~0.3  frequency (4/1369) in subjects with ASD. Based on the same studies, the estimated%
frequency of idic( ) is ~0.2  (3/1369) and that of paternal duplications ~0.1  (2/1369). Note however, that the frequency of idic( )15 % % 15 
may be underestimated because previous studies included an unknown proportion of subjects that had been screened for cytogenetic
abnormalities prior to inclusion. It also should be noted that none of these studies were based on epidemiological samples and the
possibility of ascertainment biases cannot be excluded.
Maternal versus paternal duplications
Interstitial duplications of 15q11-q13 of maternal origin are associated with developmental delay and/or autistic behavior, whereas
paternally-derived duplications usually lead to a normal phenotype ( , , , ). However, as shown in , there have been at10 15 16 18 Table 2 
least six reports of paternal duplications encompassing the PWS/AS region associated with an abnormal phenotype, including mental
retardation, delayed or absent speech, and ASD or autistic behavior ( ). In addition, two patients with an interstitial 15q11-q1337 –41 
triplication of paternal origin have been reported ( , ). Together with the patient with the paternal duplication described here, these42 43 
findings suggest that paternally-derived duplications may lead to phenotypic effects, including autism. Thus, there may be other genetic
and/or environmental/epigenetic factors operating to modify the penetrance and expressivity of paternal duplications. Similar as yet
unknown factors could come into play to modify the phenotypic expression of maternal 15q11-q13 duplications, which are also associated
with a wide range of developmental problems and show marked clinical variability among members of the same family, including
individuals who appear unaffected ( ).16 
It is interesting to note that several of the patients with paternally-inherited duplications or triplications described previously had
Prader-Willi syndrome-like features ( ) ( , , ), suggesting a role of paternally-expressed genes mapping within the PWS/ASTable 2 38 40 43 
region (e.g., and in the phenotypic manifestations. Several recent studies have shown thatMKRN3, MAGEL2, NDN, SNRPN-SNURF) 
ASD is more prevalent in Prader-Willi syndrome patients than was previously thought ( ), in agreement with a contribution of44 
paternally-expressed genes to the ASD phenotype. Further research is needed to examine the effect of parental origin on phenotypic
outcomes of 15q11-q13 duplications and their contribution to ASD. In particular, studies of gene expression in tissues from patients with
paternal duplications may improve our understanding of the effect of these rearrangements on phenotype.
Angelman syndrome and ASD
The prevalence of Angelman syndrome is estimated at 1/12,000 ( ). Angelman syndrome is characterized by severe mental45 
retardation, profound speech impairment, ataxia, and typical behavior including happy disposition with frequent laughter/smiling and
hand-flapping. Seizures, microcephaly and distinctive physical traits (large open mouth, widely-spaced teeth, prognathism) are also
common ( ). It is caused by deficiency of the maternally-inherited gene, resulting from deletion of the maternal 15q11.2-q1346 UBE3A 
region (70 ), paternal uniparental disomy (2 ), mutations (10 ), or imprinting defects (5 ), with no molecular abnormality% % UBE3A % %
identified in the remaining patients ( ).13 
The association between Angelman and autism has been known for more than a decade ( ). According to recent data, 62  (38/61,45 %
range 50 81 ) of subjects with Angelman syndrome meet criteria for autism or ASD ( ), suggesting that ASD may be part of the%– % 19 –21 
behavioral phenotype of Angelman syndrome. Although the diagnosis of ASD in Angelman syndrome is complicated by the severe
intellectual disability usually observed in these patients, there is clear evidence for ASD in a subgroup of Angelman patients who exhibit
social and communication deficits that are disproportionate to their overall cognitive function. There is little information about the
prevalence of Angelman syndrome in ASD. Schroer found one maternal 15q11-q13 deletion among 100 patients with autism ( ). Inet al. 10 
this study, we identified two subjects with Angelman syndrome, one with a maternal deletion and the second with a uniparental disomy,
for a ~0.5  frequency.%
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Because certain features of autism overlap with those seen in Angelman syndrome, including severe mental retardation, absence of
speech or very limited language, epilepsy and/or abnormal EEG, and stereotyped behaviors, the diagnosis of Angelman syndrome may be
overlooked in patients with ASD, as happened with our two patients. Although neither patient exhibited the classical phenotype, their
clinical presentation is within the normal range of phenotypic variability observed in Angelman syndrome. In common with the majority
of patients with Angelman, they exhibited severe cognitive impairment and limited or absent language, but had no ataxia or microcephaly,
and seizures and unprovoked laughter (during infancy only) were observed only in one.
BP1-BP2 microdeletions/microduplications
We identified three deletions and two duplications of the region between BP1 and BP2, all inherited from unaffected parents. A
BP1-BP2 deletion was reported recently in a boy with mental retardation, speech delay and neurological deficits, but the interpretation was
complicated by the presence of the same deletion in the father, who also showed cognitive impairment ( ). Copy number gains and47 
losses of this region have also been identified in genome-wide array analyses of control individuals (Database of Genomic Variants, 
), with a population frequency estimated at 1  ( ), suggesting that this may be a copy numberhttp://projects.tcag.ca/variation/ % 48 
polymorphism. In agreement with this interpretation, individuals carrying small idic( ) with extra copies of the four genes included in15 
the BP1-BP2 interval but that do not carry extra genomic material distal to BP2 are phenotypically normal ( ), suggesting that these31 
genes do not exert clinically significant dosage effects.
Nevertheless, it is interesting to note that and have been suggested to modulate the PWS/ASNIPA1, NIPA2, CYFIP1 TUBGCP5 
phenotype. Angelman patients with class I deletions (including the BP1-BP2 interval) are more likely to meet criteria for autism and lack
vocalizations compared with patients having smaller class II deletions ( ). Similarly, in Prader-Willi syndrome, class I deletions are20 
associated with more obsessive-compulsive behaviors and lower intellectual ability ( ), and mRNA levels of these four genes are49 
positively correlated with better behavioral outcomes ( ). More recently, BP1-BP2 deletions were shown to be significantly associated50 
with schizophrenia ( ), suggesting that these variants may increase risk for various neuropsychiatric phenotypes, albeit with low51 
penetrance and/or variable expressivity.
One of the genes situated in this interval, is particularly interesting in the context of ASD. CYFIP1 interacts with fragile XCYFIP1, 
mental retardation protein (FMRP) as well as with the Rho GTPase Rac1, which plays a role in the regulation of axonal migration and
dendritic spine morphology. CYFIP1 has been proposed as a potential molecular link between fragile X syndrome and 15q11-13
duplication, since both disorders result in excess free CYFIP1 ( ). In order to test the possibility that the BP1-BP2 deletion unmasked a52 
recessive mutation on the other chromosome we sequenced as well as and genes encoding fragileCYFIP1, NIPA1, NIPA2, TUBGCP5, 
X-related proteins and in patients carrying BP1-BP2 deletions, identifying no mutations. Clearly, more research is(FMR1, FXR1 FXR2), 
required to determine the phenotype correlations of BP1-BP2 deletions and duplications and the role of , , and NIPA1 NIPA2 CYFIP1 
, if any, in neurodevelopmental disorders.TUBGCP5 
Conclusion
The present findings confirm that genetic abnormalities of the 15q11-q13 region are an important cause of ASD, accounting for
approximately 1  of cases. Our results suggest that patients with ASD, particularly those with mental retardation, should be systematically%
screened for duplications, deletions and methylation abnormalities of the PWS/AS region. Routine chromosomal analysis, currently
recommended in the etiological evaluation of individuals with autism, would miss many of the deletions and duplications in the 15q11-q13
region, as well as cases resulting from uniparental disomy. Traditional cytogenetic tests such as FISH are expensive and would miss some
duplications and all cases of uniparental disomy. Furthermore, array-based methods are also expensive and currently are not in wide use
for detecting methylation changes. Methylation-sensitive MLPA allows simple, rapid, accurate and economic screening of dosage
imbalances and imprinting defects in this region, providing detailed information on the parental origin and the extent of the rearrangement,
and appears thus as a method of choice to screen chromosome 15 abnormalities in patients with ASD.
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Figure 1
Map of chromosome 15 showing the Prader-Willi/Angelman syndrome critical region. Genes are shown above the map and microsatellites
below. The five microsatellite markers used in the quantitative analysis are indicated in bold. Paternally and maternally expressed genes are
indicated in yellow and pink, respectively. The recurrent breakpoints (BP) are indicated as purple boxes. The imprinting center (IC), located in
the 5  untranslated region of , is indicated in green. The horizontal red bars indicate the regions deleted in Angelman and Prader-Willi′ SNRPN 
syndromes (class I and class II deletions), as well as the recently described copy number variant between BP1 and BP2 and the 15q13.3
microdeletion syndrome. The horizontal green bars indicate the regions involved in typical interstitial duplications and supernumerary
isodicentric chromosome 15. The critical region for Prader-Willi, Angelman and 15q11-q13 duplication syndromes lies between BP2 and
BP3. The distance (expressed in Mb from pter) is shown at the top of the map.
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Figure 2
Supernumerary isodicentric chromosome 15 in Patient 1. A. Metaphase FISH of lymphoblastoid cell lines from Patient 1 using probes
UBE3A (red) for the region of interest and D15S936 (green) as a control probe in 15q26.3 showed two normal signals on chromosomes 15 as
well as additional hybridization spots of the duplicated 15q11-q13 region (red) on a supernumerary chromosome (arrow). B. Quantitative
microsatellite analyses showed increased dosage of D15S11, D15S817 and D15S815 in the proband, but not in her parents. C. MPLA
confirmed increased copy number of all the probes in the 15q11-q13 region between BP1 and BP4 (from TUBGCP5 to APBA2), and normal
dosage of BLM and IGF1, located at the distal end of the chromosome, at 15q26. The peak heights above 1.5 are consistent with tetrasomy of
the region. D. Genotyping of microsatellites in the 15q11-q13 region revealed three alleles for informative markers between BP1 and BP4,
with one allele of paternal origin and two of maternal origin. The presence of one informative microsatellite, D15S1031, with a single
maternal allele indicates that the breakpoint lies proximal to this marker. E. Genomic qPCR showed a transition from increased copy number
to normal dosage between KLF13 and OTUD7A, indicating that the distal breakpoint lies between BP4 and BP5.
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Figure 3
Methylation-sensitive MLPA of the chromosome 15q region. Histograms show the dosage of probes located in the and SNRPN NDN 
promoter regions in undigested and digested DNA. In undigested DNA, both the maternal and paternal copies of the genes are visible.
Because and are paternally imprinted, after digestion with the methylation-sensitive enzyme only the maternallySNRPN NDN HhaI 
methylated DNA sequences are amplified, indicated by the light-colored bars. In a normal subject (control), a 50  reduction in peak height is%
observed after digestion. Patient 1, who has an isodicentric chromosome 15, shows 4 copies of the probes in the PWS/AS region, and a
twofold increase in peak height of methylated DNA sequences, corresponding to a maternal origin of the extra chromosome. Patient 2 shows
no increase in amplification of methylated DNA sequences after digestion, as expected with a duplication of paternal origin. Patient 3, with an
Angelman syndrome resulting from a maternal deletion of chromosome 15q11-q13, shows a 50  reduction in peak height of probes in the%
PWS/AS region, and absent methylated DNA peaks after digestion. Patient 4, with Angelman syndrome resulting from a paternal uniparental
disomy, shows normal peak heights before digestion with and an absence of methylated DNA peaks afterwards, indicating the presenceHhaI, 
of two paternal chromosomes.
Figure 4
Paternally inherited interstitial duplication of chromosome 15 in family ASD 2. MPLA showed increased gene dosage of all the genes from 
to between BP2 and BP3, while the genes before BP2 ( and ) and after BP3 ( ) showed normalMKRN3 OCA2, TUBGCP5 CYFIP1 APBA2 
dosage.
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Figure 5
Two patients with ASD and Angelman syndrome, one secondary to a maternal deletion (family ASD 3) and the other to a paternal uniparental
disomy (family ASD 4). A. Microsatellites D15S817 and D15S1019 show loss of heterozygosity, with apparently only one allele inherited
from the father in both probands. B. Genotyping of five microsatellites in the 15q11-q13 region confirmed the presence of only one allele
inherited from the father in Patient 3, indicating a maternal deletion. Patient 4 showed two alleles inherited from the father, indicating a
paternal uniparental disomy. C. MPLA showed normal gene dosage in Patient 4, as expected in an uniparental isodisomy, and a 50%
reduction in probes ranging from to in Patient 3, showing a class I deletion of the PWS/AS region.TUBGCP5 OCA2 
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Table 1
Clinical features of patients with rearrangements of the 15q11-q13 region
Patient Rearrangement
O r i g i n
(chromosome) Gender
Age at
l a s t
evaluation ASD
Developmental
delay Language Epilepsy Other features
Pathogenic rearrangements
 
Patient
1
i d i c (15 )
(pter-15q13.3,
distal BP between
BP4/BP5)
de  novo 
(maternal)
F 30 y Autism Severe MR N o
language
Absence
seizures,
resistant to
treatment (onset
13 y)
Feeding difficulties, psychomotor delay, dysmorphic features (large bulbous nose, dental
malposition, prominent jaw), short stature
 
Patient
2
interstitial
duplication
(BP2-BP3)
paternal M 6 y Autism Moderate MR Speech
delay, no
phrases
No Frequent otitis, mastication/swallowing difficulties, no dysmorphic features
 
Patient
3
deletion BP2-BP3
(Class I)
de  novo 
(maternal)
M 24 y Autism Severe MR N o
language
No Sleep difficulties, delayed motor development, gait difficulties and inappropriate laughter
during infancy, unilateral renal hypoplasia, strabismus, tongue protrusion, no dysmorphism,
normal head circumference, normal brain CT, normal EEG
 
Patient
4
pa te rna l
uniparental
disomy
de novo 
(paternal)
M 18 y Autism Severe MR Limited
language,
no phrases
Absence seizures
since early
childhood;
seizure-free at
present
Normal motor development, hyperactivity, aggressiveness, sleep difficulties, minor
dysmorphic features (slightly bulbous nose, dysplastic ears, widely spaced teeth), tapering
fingers, hyperextension of finger joints, bilateral genu valgum, pyramidal syndrome, slightly
spastic gait, no inappropriate laughter, normal head circumference
Copy number variants likely non pathogenic
 
Patient
5
deletion BP1-BP2 paternal M 5 y Autism Severe MR N o
language
N o  ( b u t
abnormal EEG)
Hypotonia, motor delay, frequent respiratory infections during infancy, macrocephaly,
retrognathia, normal brain MRI
 
Patient
6
deletion BP1-BP2 maternal F 13 y Autism Normal IQ No speech
delay
No Developmental coordination disorder, depression. The mother, who also carries the deletion,
has panic disorder and depression
 
Patient
7
deletion BP1-BP2 paternal F 9 y Autism Normal IQ No speech
delay
No ADHD combined type. Two older sisters also carry the deletion, one with ADHD and the
other with dyslexia, while the younger healthy brother did not inherit the deletion.
 
Patient
8
duplication
BP1-BP2
maternal M 5 y Autism Severe MR Functional
language
Yes (onset 9 m) Normal brain MRI
 
Patient
9
duplication
BP1-BP2
paternal M 15 y Autism Severe MR N o
language
1 absence
seizure at 11 y
Neonatal overgrowth, macrocephaly and increased height persist, long narrow hands and feet
 
Patient
10
deletion ex 1 
UBE3A
paternal M 6 y Autism Mild MR Severe
language
impairment
No No dysmorphic features, normal neurological exam
ADHD, attention deficit hyperactivity disorder; ASD, autism spectrum disorder; BP, breakpoint; CT, computed tomography; EEG, electroencephalogram; idic( ), isodicentric chromosome 15; MR,15 
mental retardation; MRI, magnetic resonance imaging
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Table 2
Patients with paternally-derived interstitial duplications or triplications of chromosome 15q11-q13 with an abnormal phenotype reported in the literature
Study Rearrangement Sex Age Clinical characteristics
Mohandas 1999 ( )et al., 39 duplication (at least
BP2-BP3)
M 2 y,
4
mo
developmental delay, absent speech, partial agenesis of the corpus callosum and heterotopic gray matter in the right hemisphere; no
dysmorphic features
Engelen ., 1999 ( )et al 38 duplication (at least
BP2-BP3)
M 12 y features similar to Prader-Willi syndrome, including developmental delay, obesity starting during the first year of life, mild mental
retardation, excessive eating, skin picking, minor dysmorphic features (high forehead, upslanting palpebral fissures), myopia, and
small hands
Mao 2000 ( )et al., 40 duplication (at least
BP2-BP3)
M 16 y developmental and speech delay, behavioral problems (mood liability, social immaturity), uncontrolled appetite, food stealing,
self-injurious behavior, depression and anxiety, low average IQ, short stature, obesity, no dysmorphic features
Roberts 2002, Bolton et al., et al., 
2004, Veltman 2005 ( , , et al., 37 53 
)54 
duplication BP1-BP3 F 5 y proband: motor and speech delay delay, PDD-NOS, borderline mental retardation, clumsy and uncoordinated, stiff gait, mild
hypotonia, joint laxity, slight down-slanting palpebral fissures
duplication BP1-BP3 F 8 y older sister: language and speech delay, developmental motor coordination disorder, oppositional defiant behavior, encopresis, autistic
behavior when younger but no ASD at 8 y, low average IQ; clumsy, mild hypotonia, joint laxity*
Smith 2004 ( )et al., 41 duplication BP2-BP3 F 17 y hypotonia, development and speech delay, autism, dyscalculia, short stature, minimal dysmorphism and motor coordination problems;
normal IQ
Cassidy 1996 ( )et al., 42 triplication BP2-BP3(BP1-2 not studied) (BP3-4
normal)
F 6 y neonatal hypotonia, difficulty feeding, motor and speech delay (words 2.5 y, phrases 6 y), violent and repetitive behavior, high pain
tolerance, short stature, wide mouth, normal neurological exam
Ungaro ., 2001 ( )et al 43 triplication BP1-BP4 F 12 y features similar to Prader-Willi syndrome, including mild mental retardation, cleft palate, obesity, compulsive eating, small hands andfeet, and short stature
All rearrangements included the Prader-Willi syndrome/Angelman syndrome critical region. All duplications/triplications were characterized molecularly and parental transmission was assessed with
methylation studies, except Engelen ( ) who determined parental origin based on cytogenetic polymorphisms, and Smith ( ), who used microsatellite analysis. In addition, Engelen (et al. 38 et al. 41 et al. 
) observed the duplication with FISH but microsatellite analysis showed no duplication and the methylation pattern was normal, thus making this case questionable.38 
 * Another sibling, who did not carry the duplication, also had mild hypotonia and a history of marked speech delay and articulatory dyspraxia, while the mother had delayed speech and troubles with
reading and writing in school.
Abbreviations: ASD, autism spectrum disorder; BP, breakpoint, PDD-NOS, pervasive developmental disorder not otherwise specified
